Frequency of BRAF V600E immunoexpression in ameloblastomas: a multi-institutional analysis of 86 cases in Latin America and comprehensive review of the literature
FM. Silveira(Universidad de la República de Uruguay), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana), Mariana Villarroel‐Dorrego(Central University of Venezuela), Oscar Almeda-Ojeda(Universidad de la República de Uruguay), M.M. Paparella(Universidad de Buenos Aires), M. Hernadez(University of Chile), Vanesa Pereira‐Prado(Universidad de la República de Uruguay), LF. Schuch(Universidad de la República de Uruguay), Estefanía Sicco(Universidad de la República de Uruguay)
Cited by 7
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58